Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.2 USD | +2.49% | +5.23% | +4.14% |
May. 17 | Sector Update: Health Care Stocks Softer Friday Afternoon | MT |
May. 17 | Doximity's Shares Rise After Truist Securities Price Target Raise Following Fiscal Q4 Results | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 39.08 and 34.83 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.14% | 5.41B | C+ | ||
+27.66% | 452B | B | ||
+33.20% | 279B | D+ | ||
+11.91% | 144B | A- | ||
+7.98% | 93.32B | C- | ||
+25.11% | 91.51B | B+ | ||
+70.03% | 63.37B | B- | ||
+15.32% | 46.64B | C+ | ||
+25.04% | 36.22B | C+ | ||
-11.83% | 31.47B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DOCS Stock
- Ratings Doximity, Inc.